Ausgewählte Publikationen von Frau Prof. Haubitz

M. Bingel, G. Lonnemann, S. Shaldon, K. M. Koch, C. A. Dinarello. Human interleukin-1 production during hemodialysis. Nephron 43: 161-163, 1986

M. Bingel, G. Lonnemann, K. M. Koch, C. A. Dinarello, S. Shaldon. Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1:14-16, 1987

M. Bingel, G. Lonnemann, K. M. Koch, C. A. Dinarello, S. Shaldon. Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes. Nephron 50: 273-276, 1988

M. Bingel, W. Arndt, M. Schulze, J. Flöge, S. Shaldon, K. M. Koch, G. Götze. Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay. Nephron 51: 320-324, 1989

M. Haubitz, M. Schulze, K. M. Koch. Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transplant 5: 500-503, 1990

M. Haubitz, U. Frei, U. Rother, R. Brunkhorst, K. M. Koch. Cyclophosphamide pulse therapy in Wegener´s Granulomatosis. Nephrol Dial Trans 6: 531-535, 1991

M. Haubitz, B. Klöppel, G. Lonnemann, B. Nonnast-Daniel. In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapy. Clin Nephrol 38: 30-35, 1992

M. Haubitz, R. Brunkhorst, E. Wrenger, P. Froese, M. Schulze, K. M. Koch. Chronic induction of C-reactive protein by hemodialysis, but not by peritonealdialysis therapy. Peritoneal Dialysis Int 16: 158-162, 1996

M. Haubitz, V. Kliem, K. M. Koch, B. Nashan, H. J. Schlitt, R. Pichlmayr, R. Brunkhorst. Renal transplantation for patients with autoimmune diseases. Single-center Experience on 42 patients. Transplantation 63: 1251-1257, 1997

M. Haubitz, P. Schulzeck, S. Schellong, M. Schulze, K. M. Koch, R. Brunkhorst. Complexed plasma elastase as an in vivo marker for leucocyte activation in ANCA-associated vasculitis. Arthritis Rheumat 40: 1680-1684, 1997

M. Haubitz, K. M. Koch, R. Brunkhorst. Cyclosporine for the prevention of disease reactivation in relapsing ANCA-associated vasculitis. Nephrol Dial Transplant 13: 2074-2076, 1998

M. Haubitz, K. M. Koch, R. Brunkhorst. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener´s granulomatosis. Nephrol Dial Transplant 13: 1713-1718, 1998

M. Haubitz, S. Schellong, U. Göbel, H.J. Schurek, D. Schaumann, K.M. Koch, R. Brunkhorst. Intravenous cyclophosphamide pulse administration versus daily oral treatment in patients with ANCA-associated vasculitis and renal involvement. Arthritis Rheumat 41: 1835-1844, 1998

M. Haubitz, T. Busch, M. Gerlach, S. Schäfer, R. Brunkhorst, K. Falke, K.M. Koch, H. Gerlach. Exhaled nitric oxide in patients with Wegener´s granulomatosis. European Respir J 14: 113-117, 1999

M. Haubitz, R. Brunkhorst. C-reactive protein and chronic chlamydia pneumoniae infection- long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16: 809-815, 2001

M. Haubitz, M. Gerlach, H.J. Kruse, R. Brunkhorst. Endothelial Tissue factor stimulation by proteinase 3 and elastase. Clin Exp Immunol 126: 584-588, 2001

M. Haubitz, F. Bohnenstengel, R. Brunkhorst, M. Schwab, U. Hofmann, D. Busse. The effects of renal insufficiency and hemodialysis on pharmacokinetics of cyclophosphamide in patients with autoimmune diseases. Kidney Int 61:1495-1501, 2002

Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells are a new marker in ANCA-associated small-vessel vasculitis. Lancet

Woywodt A, Bahlmann FH, De Groot K, Haller H, Haubitz M.
Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer.
Nephrol Dial Transplant. 2002 Oct;17(10):1728-30.

Birck R, Warnatz K, Lorenz HM, Choi M, Haubitz M, Grunke M, Peter HH, Kalden JR, Gobel U, Drexler JM, Hotta O, Nowack R, Van Der Woude FJ.
15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.
J Am Soc Nephrol. 2003 Feb;14(2):440-7.

Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M.
Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis.
Lancet. 2003 Jan 18;361(9353):206-10.

Woywodt A, Schroeder M, Mengel M, Schwarz A, Gwinner W, Haller H, Haubitz M.
Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage.
Hypertension. 2003 Mar;41(3 Pt 2):720-3. Epub 2003 Jan 20.

Woywodt A, Schroeder M, Gwinner W, Mengel M, Jaeger M, Schwarz A, Haller H, Haubitz M.
Elevated numbers of circulating endothelial cells in renal transplant recipients.
Transplantation. 2003 Jul 15;76(1):1-4.

Woywodt A, Scheer J, Hambach L, Buchholz S, Ganser A, Haller H, Hertenstein B, Haubitz M.
Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation.
Blood. 2004 May 1;103(9):3603-5. Epub 2004 Jan 8.

Fiebeler A, Borgmann S, Woywodt A, Haller H, Haubitz M.
No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
Nephrol Dial Transplant. 2004 Apr;19(4):969-71.

Woywodt A, Goldberg C, Scheer J, Regelsberger H, Haller H, Haubitz M.
An improved assay for enumeration of circulating endothelial cells.
Ann Hematol. 2004 Aug;83(8):491-4. Epub 2004 May 28.

Haubitz M, Votsch K, Woywodt A, Nashan B, Groh A, Haller H, Brunkhorst R.
Serologic evidence of Chlamydia pneumoniae infection as a long-term predictor of cardiovascular death in renal transplant recipients.
Transplantation. 2004 May 27;77(10):1517-21.

Woywodt A, Haubitz M, Buchholz S, Hertenstein B.
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2004 Dec;34(12):1015-23.